Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00046787
Status:
COMPLETED
Last Update Posted:
2011-10-20
First Post:
2002-10-03
Brief Title:
Efficacy and Safety Study of OSI-211 Liposomal Lurtotecan to Treat Recurrent Small Cell Lung Cancer
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Carcinoma Small Cell |
| SCLC |
Keywords:
| Name | View |
|---|---|
| Small Cell Lung Cancer | View |